Jie Xiao Selected Research

Jie Xiao Research Topics

Disease

32	Neoplasms (Cancer) 02/2021 - 05/2009
16	Inflammation (Inflammations) 02/2022 - 01/2014
11	Infections 06/2022 - 02/2010
10	Hypertension (High Blood Pressure) 10/2021 - 10/2010
9	Hypoxia (Hypoxemia) 01/2022 - 10/2012
7	Fibrosis (Cirrhosis) 12/2022 - 04/2009
7	Colitis 02/2022 - 01/2020
6	Leukemia 01/2022 - 08/2009
5	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 10/2016
5	Pain (Aches) 01/2022 - 07/2008
5	Obesity 10/2021 - 06/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2010
4	Chronic Renal Insufficiency 12/2022 - 01/2011
4	Pancreatitis 06/2022 - 01/2019
4	Diabetes Mellitus 10/2021 - 10/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2011
4	Neuroinflammatory Diseases 10/2021 - 02/2016
4	Myocardial Infarction 01/2021 - 01/2016
4	Wounds and Injuries (Trauma) 09/2020 - 01/2017
4	Carcinogenesis 06/2020 - 02/2010
4	Reperfusion Injury 01/2018 - 01/2003
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 12/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2022 - 01/2018
3	Dysbiosis 01/2022 - 12/2020
3	Hypersensitivity (Allergy) 01/2022 - 06/2020
3	Stroke (Strokes) 01/2022 - 07/2021
3	Cognitive Dysfunction 10/2021 - 02/2016
3	Bacterial Infections (Bacterial Infection) 01/2021 - 11/2019
3	Atherosclerosis 07/2020 - 01/2018
3	Abdominal Aortic Aneurysm 07/2020 - 01/2020
3	Osteoporosis 01/2020 - 04/2016
3	Rupture 01/2020 - 02/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 09/2016
3	Atherosclerotic Plaque (Atheroma) 04/2019 - 02/2016
3	Ischemia 01/2018 - 01/2003
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015 - 01/2014
2	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 10/2021
2	Paralysis (Palsy) 04/2022 - 03/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 08/2013
2	Heart Failure 01/2022 - 10/2018
2	Ganglion Cysts (Ganglion) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 11/2021 - 10/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 01/2015
2	Insulin Resistance 10/2021 - 09/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2021 - 01/2021
2	Neutropenia 10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2016
10	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
10	CholesterolIBA 03/2014 - 10/2010
9	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2011
9	Pharmaceutical PreparationsIBA 01/2022 - 08/2009
9	Biological ProductsIBA 01/2022 - 01/2014
6	CytokinesIBA 02/2022 - 08/2013
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2013
5	Messenger RNA (mRNA)IBA 12/2021 - 01/2003
5	Small Interfering RNA (siRNA)IBA 10/2018 - 01/2014
5	CotinineIBA 01/2014 - 01/2013
4	Circular RNAIBA 12/2022 - 01/2016
4	AntioxidantsIBA 04/2022 - 04/2020
4	Long Noncoding RNAIBA 01/2022 - 12/2017
4	ElectrolytesIBA 12/2021 - 01/2015
4	Apolipoproteins E (ApoE)IBA 07/2020 - 01/2017
4	Angiotensin IIIBA 07/2020 - 01/2015
4	NeuropeptidesIBA 06/2020 - 04/2016
4	Therapeutic UsesIBA 01/2018 - 07/2008
4	perfluorooctanoic acidIBA 03/2014 - 01/2011
3	salvinIBA 04/2022 - 03/2019
3	Dextran SulfateIBA 02/2022 - 06/2020
3	Capsaicin (Zostrix)FDA Link 01/2022 - 09/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2016
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 02/2016
3	trilaciclibIBA 01/2022 - 01/2021
3	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2016
3	Polysaccharides (Glycans)IBA 06/2021 - 10/2016
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2020 - 01/2017
3	Hemostatics (Antihemorrhagics)IBA 04/2019 - 10/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 02/2009
3	perfluorooctaneIBA 03/2014 - 01/2011
3	EnzymesIBA 02/2013 - 02/2010
2	Streptozocin (Streptozotocin)FDA Link 08/2022 - 01/2021
2	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 03/2022
2	Imatinib Mesylate (Gleevec)FDA Link 04/2022 - 01/2018
2	Peptides (Polypeptides)IBA 04/2022 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 04/2022 - 01/2018
2	PolyphenolsIBA 04/2022 - 02/2022
2	LipidsIBA 03/2022 - 01/2017
2	Inosine Triphosphate (ITP)IBA 01/2022 - 08/2013
2	salicylhydroxamic acid (SHAM)IBA 12/2021 - 08/2021
2	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 09/2020
2	Analgesics (Analgesic Drugs)IBA 11/2021 - 04/2020
2	von Willebrand FactorIBA 11/2021 - 09/2020
2	Morphine (MS Contin)FDA LinkGeneric 11/2021 - 01/2016
2	Cyclic AMP Receptors (Cyclic AMP Receptor)IBA 11/2021 - 09/2020
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021 - 07/2021
2	Sirtuin 1IBA 10/2021 - 01/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 01/2019

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2005
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
3	Transplantation 01/2022 - 01/2019
2	Electroacupuncture 01/2022 - 01/2003